Key facts
- It has raised $1.2M; the latest was Early Stage VC ($750K) in Mar 2025.
- Notable investors include Eleven Ventures, Fil Rouge Capital, The Athens Startup Business Incubator.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Vivian Lab
- ·The full record, as it builds
Funding rounds
No funding rounds for Vivian Lab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vivian Lab
Provider of a digital companion platform intended to support longevity and menopause care through personalized guidance and monitoring. The company's platform offers evidence-based health guidance, patient engagement journeys, education, remote monitoring, and clinical workflow integration, enabling pharmaceutical companies, clinics, and hospital systems to improve patient outcomes and long-term population health management.
- Sector
- Healthcare
- HQ
- Athens, Greece
- Founded
- 2023
- Employees
- 8
- Website
- vivianlab.com/
- Ownership
- Privately Held (backing)
Vivian Lab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vivian Lab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vivian Lab in its N-PORT filings yet. We sweep new filings monthly.